Under the liquidity contract entrusted by Innate Pharma to Gilbert Dupont, the following assets appeared on the liquidity account as at December 31, 2012:
- 86,829 shares of Innate Pharma, and
- 150,918.73 euros in cash
| PR in English | 37.01 KB |
| CP en français | 28.97 KB |